Business Development, Generic Drugs and In-Vitro

Using FDA Product Specific Guidances (PSGs) as a Trigger for Generic Drug Development

Drug Patent Watch

DECEMBER 11, 2024

Generic drugs play a crucial role in providing affordable healthcare options to millions of patients worldwide. One of the key tools that generic drug manufacturers rely on to navigate the complex regulatory environment is the FDA’s Product Specific Guidances (PSGs). ” – Dr. .”

Generic Drugs

Generic Drugs Production Development Bioequivalency

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

MAY 4, 2021

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 per share amounts).

Vaccination

Vaccination Vaccine Production Sales

Clinical Research Informer

Using FDA Product Specific Guidances (PSGs) as a Trigger for Generic Drug Development

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

Webinars

Stay Connected